Mathias Mericskay
Orsay, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Author Correction: Myocardial disarray drives metabolic inefficiency in human cardiomyocytes.
Journal: Communications biology
Published: May 23, 2026
Sex-specific benefits of a combined supplementation of B vitamins, nicotinamide riboside, folate and cobalamin, in a murine model of heart failure.
Journal: Biology of sex differences
Published: May 20, 2025
Sex-specific modulation of cardiac fibrosis and lipid metabolism by B-vitamins in heart failure with reduced ejection fraction in mice.
Journal: American journal of physiology. Heart and circulatory physiology
Published: May 12, 2025
Cardiac intermediary metabolism in heart failure: substrate use, signalling roles and therapeutic targets.
Journal: Nature reviews. Cardiology
Published: May 01, 2025
Nicotinamide Riboside: A Promising Treatment for Type 1 Cardiorenal Syndrome in Myocardial Infarction-Induced Acute Kidney Injury by Upregulating Nicotinamide Phosphoribosyltransferase-Mediated Nicotinamide Dinucleotide Levels.
Journal: Journal of the American Heart Association
Published: February 26, 2025
Myocardial disarray drives metabolic inefficiency in human cardiomyocytes.
Journal: Communications biology
Published: October 18, 2024
Nicotinamide riboside: A promising therapy for MI-induced acute kidney injury by upregulating nicotinamide phosphoribosyltransferase-mediated NAD levels.
Journal: bioRxiv : the preprint server for biology
Published: September 24, 2024
Preventing the Fatty Acid-Transporter CD36 From Taking its Toll on the Heart.
Journal: Circulation research
Published: February 29, 2024
Nicotinamide Riboside Supplementation Restores Myocardial Nicotinamide Adenine Dinucleotide Levels, Improves Survival, and Promotes Protective Environment Post Myocardial Infarction.
Journal: Cardiovascular drugs and therapy
Published: November 10, 2023
Potential Alternative Receptors for SARS-CoV-2-Induced Kidney Damage: TLR-4, KIM-1/TIM-1, and CD147.
Potential Alternative Receptors for SARS-CoV-2-Induced Kidney Damage: TLR-4, KIM-1/TIM-1, and CD147.
Journal: Frontiers in bioscience (Landmark edition)
Published: October 17, 2023
Modulation of cardiac cAMP signaling by AMPK and its adjustments in pressure overload-induced myocardial dysfunction in rat and mouse.
Journal: PloS one
Published: June 12, 2023
Assessing the outcomes of prescribing angiotensin converting enzyme inhibitors and angiotensin receptor blockers for COVID-19 patients.
Journal: Heliyon
Published: May 15, 2023
Last Updated: 09/26/2026